Press Release ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients 3 September 2026
Press Release KBRA Assigns AAA Rating to State of Wisconsin General Obligation Bonds of 2026, Series B 3 September 2026
Press Release Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) 3 September 2026
Press Release KBRA Assigns A- with Stable Outlook to Monterey Peninsula Airport District Airport Revenue Bonds and TIFIA Loan 3 September 2026
Press Release PNR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Pentair plc and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit – October 2, 2026 Deadline 3 September 2026
Press Release IPA Capital Markets Arranges $40.3 Million Financing for 312-Unit Birwood Heights in San Antonio 3 September 2026
Press Release Abnormal AI Brings OpenAI Daybreak Models Into AI Cloud Security to Protect Against Rogue AI 3 September 2026
Press Release eGenesis Announces Clinical Update in Ongoing Expanded Access Study of EGEN-2784 in Patients with Kidney Failure 3 September 2026
Press Release Robbins LLP Informs Investors of the Papa John’s International, Inc. Securities Class Action 3 September 2026
